FROM: Theodore O. Will, Chief Executive Officer
DATE: Nov 01, 2002
SUBJECT: Medicare 7th Scope Of Work - Overview
IPRO CONTACTS:
Spencer Vibbert, Vice President, Communications & Corporate Development, Ext. 588
IPRO's new Medicare Quality Improvement Organization (QIO) workplan, known as the Seventh Scope of Work (7SOW) went into effect on August 1, 2002. This three-year Scope of Work provides us with many opportunities to further our work in ensuring quality care to Medicare beneficiaries and directs IPRO to do the following:
Below you will find an overview of the specific tasks that will be undertaken for the new Scope of Work. We have also attached a list of Medicare's inpatient and outpatient quality measurement specifications effective August 1, 2002.
IPRO is currently working with members of the Provider Relations Committee to finalize a Memorandum of Agreement (MOA). We will shortly be sending the MOA to you for signature.
Task 1 involves designing quality improvement projects and improving clinical health outcomes for Medicare beneficiaries in nursing homes, home health agencies, hospitals, physician offices, underserved individuals and those residing in rural areas, and enrollees in Medicare + Choice Organizations (M+COs).
IPRO and skilled nursing facility providers will collaborate on improving performance on clinical quality indicators for all nursing homes in the state and for an identified sub-set of homes participating in an intensive improvement effort. Task 1a goals include:
IPRO and providers will develop partnerships to improve Outcome and Assessment Information Set (OASIS) quality of care performance measures for Home Health Agencies (HHAs) in the state and for identified participant HHAs. Specific goals include:
IPRO and the hospital community of New York State will work together to sustain and enhance the quality of care delivered to Medicare beneficiaries. The clinical conditions that CMS has chosen to focus on for this Scope of Work include acute myocardial infarction, congestive heart failure, pneumonia and reduction of post surgical infections.
IPRO 's goals regarding Task 1c include:
This subtask focuses on care delivered in outpatient settings and builds upon work conducted in the 6th Scope of Work. The conditions that this task applies to include breast cancer, diabetes and immunization.
Goals include:
IPRO and the New York provider community will work together to eliminate disparities between medically underserved seniors and the general Medicare beneficiary population.
IPRO's work on this task will be evaluated based on the following:
IPRO will collaborate with M+C plans to implement Quality Assessment and Performance Improvement (QAPI) projects to improve health outcomes and enrollee satisfaction. In addition, IPRO will be expected to have made a concerted effort to include M+COs in Tasks 1a to 1e.
IPRO will be evaluated qualitatively by the project officer, as well as by M+CO satisfaction - CMS will seek feedback from the M+COs who participated in a quality improvement project and/or received technical assistance provided by IPRO. CMS asks that at least 80% of the respondents be mostly or fully satisfied with the assistance given by IPRO.
In this scope of work, communication between IPRO, providers/practitioners, beneficiaries and caregivers will be encouraged.
CMS is committed to public release of institution - specific performance data involving nursing homes throughout the U.S., beginning in the fall of 2002.
IPRO's efforts to promote the publicly reported performance measures should contribute to the following outcomes:
The purpose of this task is to encourage hospitals to abstract and collect their own clinical data. IPRO will assess the current reporting capabilities of NYS hospitals and provide technical assistance to hospitals as they take on this responsibility.
Throughout the contract, CMS will use data collected by IPRO to measure the proportion of hospitals within the State that have implemented a data abstraction system to abstract quality of care measures.
CMS will conduct a Customer Satisfaction Survey of the appropriate personnel in all facilities where IPRO supports the ongoing use of the CMS-approved abstraction tools. CMS asks that at least 80% of the respondents be mostly or fully satisfied with the assistance given it by IPRO.
This task addresses:
IPRO will work with hospitals to ensure the health and safety of Medicare beneficiaries as well as to protect the integrity of the Medicare Trust Fund.
While still responsible for reviewing beneficiary complaints regarding care decisions, IPRO may now offer mediation between the beneficiary and the provider/practitioner to resolve those concerns when directed by CMS (target date 2003). IPRO is encouraged to work with providers to identify systems improvement opportunities.
IPRO's success on this task will be assessed by based on the following elements:
As in the 6th SOW, IPRO will continue to review all cases referred by the Clinical Data Abstraction Centers (CDACs) as part of a random sample to produce national and state specific payment error rates for coding and medical necessity.
IPRO will also monitor hospital admissions and coding patterns by conducting hospital profiling and trend monitoring, target identification activities to determine for errors and inappropriate utilization by providers. IPRO will develop project proposals to address identified and potentially significant utilizations and coding problems. All projects must be approved by CMS prior to implementation. In addition, IPRO may be directed by CMS to conduct specific error prevention projects.
CMS will evaluate IPRO's success under this task in relation to the following criteria:
In addition, IPRO must meet one of the following criteria:
IPRO will respond to beneficiaries' requests for case review to ensure that Hospital- Issued Notices of Non-coverage (HINNs)/Notice Of Discharge & Medicare Appeal Rights (NODMARS) given to Medicare beneficiaries or their designated representatives are correct and that those beneficiaries are not discharged from hospitals prematurely. In addition, IPRO must monitor content and accuracy and take HINN appropriate action to correct any identified deficiencies.
EMTALA ReviewEMTALA is more commonly known as the "anti-dumping" law. IPRO will provide independent review for cases CMS determines have violated the EMTALA. QIO review is a requisite step prior to the imposition of civil monetary penalties or a provider's termination by the Office of the Inspector General (OIG).
All Other Case Review ActivitiesIPRO will make medical necessity, quality of care, and/or DRG validation determinations (applicable to the kind of case under review). IPRO will also monitor the hospital's compliance in securing physician acknowledgement statements.
Post Review ActivitiesIPRO will exercise its authority to reopen initial determinations and DRG changes when necessary.
IPRO's success on this task will be assessed in relation to the following elements:
During the course of the 7th Scope of Work, IPRO may be asked to perform work that is not specified in Tasks 1-3, under "Special Study" designation.
Should you need additional information on the 7SOW, please do not hesitate to contact me or Spencer Vibbert at 516-326-7767, extension 588.